Logo

Molzym Gets CE Mark for Sepsis PCR Test

Sep 30, 2008
NEW YORK (GenomeWeb News) – German firm Molzym has received the CE Mark for its PCR-based test for sepsis enabling the firm to market the test throughout the European Union.
 
Molzym’s SepsiTest detects more than 345 relevant sepsis pathogens and can provide results in less than four hours. The firm claims that it is the first PCR-based assay that can detect all of the relevant strains in one test.
 
“Broad-spectrum molecular sepsis diagnostics will for the first time enable early targeted treatments and SepsiTest will greatly support clinicians in their bedside decision-making,” Michael Lorenz, chief scientist at Bremen, Germany-based Molzym, said in a statement.

Breaking News
The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.